医学
重症监护医学
2型糖尿病
内科学
1型糖尿病
糖尿病
内分泌学
作者
Vikas S. Sridhar,Ayodele Odutayo,Subhash Vishal Garg,Thomas Danne,Alessandro Doria,Michael Mauer,Michael J. Davies,Phillip Banks,Manon Girard,David Z.I. Cherney
出处
期刊:Journal of The American Society of Nephrology
日期:2024-11-01
标识
DOI:10.1681/asn.0000000540
摘要
This analysis evaluated the efficacy and safety of sotagliflozin, a dual SGLT1&2 inhibitor, added to insulin in patients with type 1 diabetes and chronic kidney disease (CKD).
科研通智能强力驱动
Strongly Powered by AbleSci AI